Arbizu T - Search Results

1

Specificity of frontal dysfunctions in relapsing-remitting multiple sclerosis.

Santiago O, Guàrdia J, Casado V, Carmona O, Arbizu T. Santiago O, et al. Among authors: arbizu t. Arch Clin Neuropsychol. 2007 Jun;22(5):623-9. doi: 10.1016/j.acn.2007.04.003. Epub 2007 May 7. Arch Clin Neuropsychol. 2007. PMID: 17482795

2

Regression to the mean in multiple sclerosis.

Martínez-Yélamos S, Martínez-Yélamos A, Martín Ozaeta G, Casado V, Carmona O, Arbizu T. Martínez-Yélamos S, et al. Among authors: arbizu t. Mult Scler. 2006 Dec;12(6):826-9. doi: 10.1177/1352458506070820. Mult Scler. 2006. PMID: 17263014

3

Multiple sclerosis and cognitive decline: is ApoE-4 a surrogate marker?

Carmona O, Masuet C, Santiago O, Alía P, Moral E, Alonso-Magdalena L, Casado V, Arbizu T. Carmona O, et al. Among authors: arbizu t. Acta Neurol Scand. 2011 Oct;124(4):258-63. doi: 10.1111/j.1600-0404.2010.01473.x. Epub 2011 Jan 6. Acta Neurol Scand. 2011. PMID: 21208197

4

[The costs of a multiple sclerosis relapse in Catalonia (Spain)].

Casado V, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Alonso L, Romero L, Moral E, Arbizu T. Casado V, et al. Among authors: arbizu t. Neurologia. 2006 Sep;21(7):341-7. Neurologia. 2006. PMID: 16977554 Spanish.

5

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.

Casado V, Romero L, Gubieras L, Alonso L, Moral E, Martinez-Yelamos S, Martinez-Yelamos A, Carmona O, Arbizu T. Casado V, et al. Among authors: arbizu t. Mult Scler. 2007 Jul;13(6):800-4. doi: 10.1177/1352458506073480. Epub 2007 Mar 15. Mult Scler. 2007. PMID: 17613609

6

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis.

Martínez-Yélamos A, Saiz A, Sanchez-Valle R, Casado V, Ramón JM, Graus F, Arbizu T. Martínez-Yélamos A, et al. Among authors: arbizu t. Neurology. 2001 Aug 28;57(4):722-4. doi: 10.1212/wnl.57.4.722. Neurology. 2001. PMID: 11524491 Free article.

7

[Interferon-beta and autoinmune hepatitis in multiple sclerosis: cause-effect or association?].

Carmona O, Gubieras L, Romero-Pinel L, Alonso-Magdalena L, Moral E, Casado V, Arbizu T. Carmona O, et al. Among authors: arbizu t. Neurologia. 2008 Sep;23(7):468-9. Neurologia. 2008. PMID: 18726728 Spanish. No abstract available.

8

Anticipation of age at onset in multiple sclerosis: methodologic pitfalls.

Alonso-Magdalena L, Romero-Pinel L, Moral E, Carmona O, Gubieras L, Ramón JM, Martínez-Yélamos S, Arbizu T. Alonso-Magdalena L, et al. Among authors: arbizu t. Acta Neurol Scand. 2010 Jun;121(6):426-8. doi: 10.1111/j.1600-0404.2009.01273.x. Acta Neurol Scand. 2010. PMID: 20578997

9

Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study.

Fernández O, Arbizu T, Izquierdo G, Martínez-Yélamos A, Gata JM, Luque G, de Ramón E. Fernández O, et al. Among authors: arbizu t. Acta Neurol Scand. 2003 Jan;107(1):7-11. doi: 10.1034/j.1600-0404.2003.01350.x. Acta Neurol Scand. 2003. PMID: 12542507 Clinical Trial.

10

Anticipation of age at onset in familial multiple sclerosis.

Romero-Pinel L, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Kremenchutzky M, Arbizu T. Romero-Pinel L, et al. Among authors: arbizu t. Eur J Neurol. 2010 Apr;17(4):572-5. doi: 10.1111/j.1468-1331.2009.02870.x. Epub 2009 Dec 7. Eur J Neurol. 2010. PMID: 20002735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters